The neurocutaneous pattern syndromes are a group of disorders characterized by congenital abnormalities involving both the skin and the nervous system for which no identifiable cause has been isolated.(1) Ophthalmologic manifestations of these syndromes are common. These rare syndromes often have overlapping ophthalmic and systemic findings. Examples include encephalocraniocutaneous lipomatosis (ECCL), oculocerebrocutaneous syndrome (OCC), and linear nevus sebaceous syndrome (LNS). Clarifying the diagnostic criteria for these syndromes is a worthy goal because it will help elucidate the phenotypic spectrum of these poorly understood diseases as well as possibly facilitate genetic counseling. In this short report, a case of ECCL is used to illustrate the clinical manifestations of neurocutaneous syndromes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/mpa.2003.S1091853103000120 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mosaic KRAS Mutation in Schimmelpenning-Feuerstein-Mims Syndrome With Overlapping Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis Features.
Pediatr Dermatol
December 2024
Department of Dermatology and Allergology, ERN-Skin Reference Center, Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
We report a patient with clinically confirmed Schimmelpenning-Feuerstein-Mims (SFM) syndrome but many overlapping features with oculoectodermal syndrome (OES) and encephalocraniocutaneous lipomatosis (ECCL). Whole exome sequencing revealed a mosaic KRAS c.436G>A, p.
View Article and Find Full Text PDFReview of encephalocraniocutaneous lipomatosis.
Semin Pediatr Neurol
December 2024
Dell Medical School, The University of Texas at Austin, Austin, TX, USA. Electronic address:
Article Synopsis
- Encephalocraniocutaneous lipomatosis (ECCL), or Haberland syndrome, is a rare condition affecting the skin, central nervous system, and eyes, characterized by tumors and other abnormalities.
- Key symptoms include specific skin lesions, subcutaneous lipomas, and neurological issues like intracranial lipomas and developmental delays.
- Diagnosis primarily relies on clinical evaluation with possible genetic testing; management is multidisciplinary, focusing on symptom relief and monitoring for potential complications.
A Hemorrhagic Brain Mass in a Child With Encephalocraniocutaneous Lipomatosis.
J Pediatr Hematol Oncol
October 2024
Division of Hematology, Oncology, and Bone Marrow Transplant, Department of Pediatrics, Seattle Children's Hospital.
Article Synopsis
- Encephalocraniocutaneous lipomatosis (ECCL) is a rare genetic disorder characterized by specific skin, eye, and brain abnormalities.
- There have been case reports linking ECCL to low-grade gliomas and certain mutations in the FGFR1 gene.
- This report highlights a patient with ECCL who has a diffuse low-grade glioma and a unique FGFR1 mutation that affects the mitogen activated protein kinase pathway.
Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the gene.
J Med Genet
August 2024
Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium.
Article Synopsis
- Encephalocraniocutaneous lipomatosis (ECCL) is a rare congenital syndrome that affects the eyes, skin, and central nervous system, linked to specific genetic variants.
- A case study of a patient with Neurofibromatosis type 1 revealed a germline pathogenic variant associated with ECCL, suggesting a broader relationship between these conditions.
- Genetic analysis indicated biallelic inactivation happening early in embryonic development, which could explain the severe abnormalities typical of ECCL, activating the RAS-MAPK pathway and demonstrating different forms of mosaicism contributing to the phenotype.
Encephalocraniocutaneous Lipomatosis: A Case Report.
Ann Plast Surg
April 2024
Department of Plastic Surgery.
Encephalocraniocutaneous lipomatosis (ECCL) is a rare congenital syndrome and subclassification of oculoectodermal syndrome. Encephalocraniocutaneous lipomatosis may be associated with postzygotic mutations. However, absence of an identifiable mutation does not preclude a diagnosis of ECCL.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!